Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
Senolytics have the potential to extend healthspan by selectively killing senescent cells (SCs), but senolytics that target Bcl-xl may cause platelet toxicity. Here, the authors generated a Bcl-xl proteolysis-targeting chimera (PROTAC) senolytic, which effectively clears SCs and rejuvenates tissue s...
Saved in:
Main Authors: | Yonghan He, Xuan Zhang, Jianhui Chang, Ha-Neui Kim, Peiyi Zhang, Yingying Wang, Sajid Khan, Xingui Liu, Xin Zhang, Dongwen Lv, Lin Song, Wen Li, Dinesh Thummuri, Yaxia Yuan, Janet S. Wiegand, Yuma T. Ortiz, Vivekananda Budamagunta, Jennifer H. Elisseeff, Judith Campisi, Maria Almeida, Guangrong Zheng, Daohong Zhou |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/dc8e747a1c2b46fbb1cf6eb91566a85f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells
by: Ryan Kolb, et al.
Published: (2021) -
Proteolysis-targeting chimeras and their implications in breast cancer
by: Angeles C. Tecalco-Cruz, et al.
Published: (2021) -
Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
by: Guliang Yang, et al.
Published: (2022) -
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,
by: Dongwen Lv, et al.
Published: (2021) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
by: Songhyun Lim, et al.
Published: (2021)